Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia

Purpose of the study. To assess the degree of influence of ischemic disorders in the prostate on the level of androgens.Materials and methods. This was an experimental study that included 20 white non-linear sexually Mature rats. All animals were divided into 2 equal groups: main and control (intact...

Full description

Saved in:
Bibliographic Details
Main Authors: G. E. Roitberg, K. G. Mkrtchyan, N. G. Kulchenko
Format: Article
Language:Russian
Published: QUASAR, LLC 2020-06-01
Series:Исследования и практика в медицине
Subjects:
Online Access:https://www.rpmj.ru/rpmj/article/view/541
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524376882642944
author G. E. Roitberg
K. G. Mkrtchyan
N. G. Kulchenko
author_facet G. E. Roitberg
K. G. Mkrtchyan
N. G. Kulchenko
author_sort G. E. Roitberg
collection DOAJ
description Purpose of the study. To assess the degree of influence of ischemic disorders in the prostate on the level of androgens.Materials and methods. This was an experimental study that included 20 white non-linear sexually Mature rats. All animals were divided into 2 equal groups: main and control (intact). In the main group of animals (n=10), we created a model of chronic ischemic disorders in the prostate by partial ligation of the inferior Vena cava. After 1.5 months, we conducted a hormonal study in all rats (n=20) — determining the concentration of androgens (testosterone, dihydrotestosterone) and estrogens (estradiol) in the blood of animals and prostate tissue.Results. In the blood of animals of both groups, the level of total testosterone and estradiol did not significantly differ (p>0.05). The level of dihydrotestosterone in the blood serum of rats of the main group on the background of ischemia was reduced by 18.1%, compared to the intact group (p>0.05). However, we detected elevated levels of testosterone (p<0.05) and dihydrotestosterone (p>0.05) in prostate tissue against the background of chronic ischemia.Conclusions. Chronic ischemic disorders in the prostate can be an independent pathogenetic factor in the development of BPH. Vascular damage leads to impaired blood flow and hypoxia, with increased tissue concentration of testosterone, which potentiates the development of BPH.
format Article
id doaj-art-b3aad29f149c4bea96ebd7b587d77d84
institution Kabale University
issn 2410-1893
language Russian
publishDate 2020-06-01
publisher QUASAR, LLC
record_format Article
series Исследования и практика в медицине
spelling doaj-art-b3aad29f149c4bea96ebd7b587d77d842025-02-03T07:12:14ZrusQUASAR, LLCИсследования и практика в медицине2410-18932020-06-0172758110.17709/2409-2231-2020-7-2-7322Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasiaG. E. Roitberg0K. G. Mkrtchyan1N. G. Kulchenko2N.I.Pirogov Russian National Research Medical University (RNRMU); “Medicinа”“Medicinа”Peoples Friendship University of Russia (RUDN University)Purpose of the study. To assess the degree of influence of ischemic disorders in the prostate on the level of androgens.Materials and methods. This was an experimental study that included 20 white non-linear sexually Mature rats. All animals were divided into 2 equal groups: main and control (intact). In the main group of animals (n=10), we created a model of chronic ischemic disorders in the prostate by partial ligation of the inferior Vena cava. After 1.5 months, we conducted a hormonal study in all rats (n=20) — determining the concentration of androgens (testosterone, dihydrotestosterone) and estrogens (estradiol) in the blood of animals and prostate tissue.Results. In the blood of animals of both groups, the level of total testosterone and estradiol did not significantly differ (p>0.05). The level of dihydrotestosterone in the blood serum of rats of the main group on the background of ischemia was reduced by 18.1%, compared to the intact group (p>0.05). However, we detected elevated levels of testosterone (p<0.05) and dihydrotestosterone (p>0.05) in prostate tissue against the background of chronic ischemia.Conclusions. Chronic ischemic disorders in the prostate can be an independent pathogenetic factor in the development of BPH. Vascular damage leads to impaired blood flow and hypoxia, with increased tissue concentration of testosterone, which potentiates the development of BPH.https://www.rpmj.ru/rpmj/article/view/541benign prostatic hyperplasia (bph)testosteronedihydrotestosteroneestradiolchronic ischemiaexperimental study
spellingShingle G. E. Roitberg
K. G. Mkrtchyan
N. G. Kulchenko
Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
Исследования и практика в медицине
benign prostatic hyperplasia (bph)
testosterone
dihydrotestosterone
estradiol
chronic ischemia
experimental study
title Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
title_full Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
title_fullStr Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
title_full_unstemmed Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
title_short Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
title_sort influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
topic benign prostatic hyperplasia (bph)
testosterone
dihydrotestosterone
estradiol
chronic ischemia
experimental study
url https://www.rpmj.ru/rpmj/article/view/541
work_keys_str_mv AT geroitberg influenceofchronicischemicdisordersintheprostateonthedevelopmentofbenignprostatichyperplasia
AT kgmkrtchyan influenceofchronicischemicdisordersintheprostateonthedevelopmentofbenignprostatichyperplasia
AT ngkulchenko influenceofchronicischemicdisordersintheprostateonthedevelopmentofbenignprostatichyperplasia